Skip to main content
Therapeutic Advances in Medical Oncology logoLink to Therapeutic Advances in Medical Oncology
. 2020 Jun 3;12:1758835920932317. doi: 10.1177/1758835920932317

Corrigendum to “Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial”

PMCID: PMC7270929  PMID: 32547649

Barni S, Rosati G, Lonardi S, et al. Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial. Ther Adv Med Oncol 2020; 12: 1-12. DOI: 10.1177/1758835919899850

In this article, the affiliation listed for author Lorenza Rimassa is incorrect. The correct affiliation is Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (MI), Italy and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.

The online version of the article has been corrected.


Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications

RESOURCES